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Abstract
Background: Early postpartum women are more likely to develop tuberculosis than nonpregnant women mainly
due to immune reconstitution after delivery. Paradoxical response (PR) during antituberculosis treatment also arises
via recovery from immunosuppression. However, no study focused on PR during antituberculosis treatment in a
postpartum patient has been reported.
Case presentation: We present two sequential cases (Patient 1: 26-year-old; Patient 2: 29-year-old) of postpartum
tuberculosis with pulmonary and extrapulmonary lesions (Patient 1: peritonitis; Patient 2: psoas abscess secondary
to spondylitis). Both cases progressed to PR (worsening of pre-existing lung infiltrations (Patients 1, 2) and new
contralateral effusion (Patient 2)) in a relatively short time after initiation of treatment (Patient 1: 1 week; Patient 2:
3 weeks), suggesting that immune modulations during pregnancy and delivery may contribute to the pathogenesis of
both disseminated tuberculosis and its PR. The pulmonary lesions and effusion of both cases gradually improved
without change of chemotherapy regimen.
Conclusion: Physicians should recognize PR in tuberculosis patients with postpartum and then evaluate
treatment efficacy.
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Background
Pregnancy is a relatively immunosuppressive state to
escape maternal anti-fetus rejection. Soon after deliv-
ery, T-helper 1 suppression was shown to reverse rap-
idly, and cellular immune reconstitution is thought to
be a major cause of postpartum exacerbation of other-
wise quiescent or latent infections [1]. Representative
infectious etiologies of exacerbation after pregnancy
include Cryptococcus neoformans, hepatitis and Herpes
viruses, and Mycobacterium tuberculosis [1, 2]. Early
(within 6 months) postpartum women are twice as
likely to develop tuberculosis as nonpregnant women
[2]. Although management of tuberculosis in pregnant
and postpartum female has been discussed [3, 4], no
study focused on paradoxical response (PR) during
antituberculosis treatment in a postpartum patient has
been reported.
PR during antituberculosis treatment is defined as the
transient clinical or radiological worsening or new for-
mation of tuberculous lesions that occur after initiation
of appropriate chemotherapy, and is not due to treat-
ment failure or the presence of another diagnosis. It is
thought that the hypersensitivity response to myco-
bacterial antigens following immune reconstitution is
the basis of PR pathogenesis [5, 6]. In this report, we
present two sequential cases of postpartum tuberculosis
with pulmonary and extrapulmonary lesions, both of
which progressed to PR to the treatment, suggesting
that immune modulations during pregnancy and deliv-
ery may contribute to the pathogenesis of both dissemi-
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A 26-year-old female with an uneventful antenatal period
delivered a full-term baby by normal vaginal delivery.
She developed persistent fever 1 month after delivery.
Chest X-ray and computed tomography (CT) showed
right pleural effusion and homonymous lung infiltration
(Fig. 1a and b), which was not observed before delivery.
Patient was initially treated as a case of bacterial
pleuropneumonia with parenteral antibiotics during
3 weeks of hospitalization with decline of fever; pleural
effusion decreased gradually for 3 months.
However, fever recurred 4 months after the delivery with
gradually worsening abdominal distention, and she was
admitted to our department. Chest X-ray and CT showed
residual lung infiltrations without cavity and effusion
(Fig. 1c and d). Abdominal CT revealed moderate ascites,
intraabdominal mass lesions and lymph nodes swelling,
and bilateral adnexal masses (Fig. 2a, b and c). Diagnostic
puncture yielded clear yellow fluid, which was consistent
with exudates. The sputum and ascites acid-fast bacillus
smear were negative, and both cultures isolated no com-
mon bacteria. However, the QuantiFERON-TB third
generation (QFT-3G) test was positive, and the diagnosis
Fig. 1 Time course of chest X-ray and CT findings of case 1 (a–h) and case 2 (i–n). a and b, Right pleural effusion and homonymous lung
infiltration 1 month after delivery. c and d, Residual lung infiltration without effusion 4 months after delivery. e and f, Worsening of pre-existing lung
infiltrations with new contralateral effusion 4 weeks after initiation of the antituberculosis treatment. g and h, Disappearance of effusion and
improvement of lung infiltrations after a course of chemotherapy (2HREZ/7HR). i and j, Multiple infiltrative shadows in lungs 6 months after
delivery. k and l, Worsening of infiltrations in the right lung 10 weeks after initiation of the antituberculosis treatment. m and n, Improvement
in lung infiltrations after a course of chemotherapy (2HREZ/7HR)
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of pulmonary and peritoneal tuberculosis was estab-
lished by the detection of M. tuberculosis DNA in
sputum and ascites utilizing PCR. Although the CA125
serum level was high (247 IU/ml), ascitic cytology did
not reveal malignant cells. Further serology tests were
negative for antinuclear antibody and HIV-Ab. Pulmon-
ary and peritoneal tuberculosis were later confirmed by
acid-fast bacilli cultures.
The patient was started on quadruple therapy (isonia-
zid, rifampin, ethambutol and pyrazinamide: HREZ).
One week after the chemotherapy was started, worsen-
ing of the pre-existing lung infiltrations with new
contralateral effusion was noted, and continued for
3 weeks (Fig. 1e and f ). Improvement of abdominal
findings was not observed in this period. However, the
chemotherapy regimen was not altered, since this strain
of M. tuberculosis was sensitive to all principal antitu-
berculous drugs. Then, the lung infiltrations and effu-
sion were gradually improved by continuation of
chemotherapy (Fig. 1g and h). The sputum acid-fast
bacilli cultures became negative and ascites disap-
peared. The CA125 serum level was reduced to the
normal range after chemotherapy.
Patient 2
A 29-year-old woman underwent a cesarean section at
36 weeks gestation. Although she began to notice left
lumbar backache 2 weeks after the operation, further
examination was not carried out. Five months later, she
was admitted to our hospital due to prominent left
lumbar backache with newly appeared productive cough.
An abdominal CT revealed spondylitis of the Th11-Th12
vertebra and a large low attenuation mass in the left
psoas muscle, at a size of 7 cm × 5 cm × 8 cm (Fig. 2d, e
and f). In addition, chest X-ray and CT showed multiple
infiltrative shadows in the lungs (Fig. 1i and j). CT-
guided percutaneous needle biopsy of the psoas abscess
was performed, obtaining a dense, purulent fluid. Acid-
fast bacillus staining and PCR tests for M. tuberculosis
of the fluid were both positive. No bacteria or fungi were
isolated from the same samples. In addition, T-SPOT.TB
was also positive. Tuberculous psoas abscess and pul-
monary tuberculosis were later confirmed by acid-fast
bacilli cultures.
The patient was started on quadruple therapy (HREZ),
and a CT-guided percutaneous drainage of the psoas ab-
scess was performed. Three week after the chemother-
apy was started, right side chest pain developed.
Subsequently, radiological worsening of infiltrations in
the right lung were observed, and continued for 7 weeks
(Fig. 1k and l). However, the pulmonary infiltrations
gradually improved without change of the chemotherapy
regimen (Fig. 1m and n). The strain of M. tuberculosis
was sensitive to all principal antituberculous drugs, and
Fig. 2 Abdominal CT findings of case 1 (a–c) and case 2 (d–f) at diagnosis. a, Moderate ascites and intraabdominal mass lesions (arrows).
b, intraabdominal lymph nodes swelling (in the circle). c, bilateral adnexal masses (in the circle). d and e, Osteosclerotic lesion of Th11-Th12
vertebra with surrounding abscess (in the circle). f, A large low attenuation mass in the left psoas muscle (in the circle)
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acid-fast bacilli cultures became negative in sputum and
needle aspiration specimens of the small residual psoas
abscess.
Discussion
During pregnancy, Th2/Th3 responses, which lead to
immunosuppressive and anti-inflammatory responses,
are enhanced and the Th1 response, which leads to pro-
inflammatory responses, is suppressed, preventing the
maternal immune system from assaulting the fetus. Ma-
ternal hormones and placental products play an import-
ant role in these immune modulations. Th2 response
facilitates the asymptomatic mycobacterial infection and
the shift from Th2 towards Th1 response during the
postpartum period induces active diseases mostly with
extrapulmonary or disseminated lesions from the latent
state. Such pathogenesis is considered to be part of im-
mune reconstitution syndrome (IRS) [1, 7], and similar-
ities between IRS and PR in tuberculosis have been
reported [8].
The fact that initiation of anti-HIV therapy for patients
with AIDS or discontinuation of anti-TNFα therapy for
patients with autoimmune disease after initiation of tu-
berculosis treatment is a representative risk factor for
PR suggests that hypersensitivity response to mycobac-
terial antigens following immune reconstitution is the
basis of PR pathogenesis [5, 6]. Increased circulating
TNFα (one of the main proinflammatory cytokines) with
concomitant clinical deterioration after the initiation of
therapy in HIV-negative (HIV−) patients with severe
tuberculosis has also been reported [9]. PR is signifi-
cantly more frequent among patients with extrapul-
monary or disseminated tuberculosis, as shown in our
patients [5, 6]. In addition, cases of paradoxical inflam-
matory reaction during treatment of cryptococcal men-
ingitis in postpartum females with or without HIV
infection were reported [10, 11]. However, to the best
of our knowledge, no study focused on PR during anti-
tuberculosis treatment in a postpartum patient has
been reported except for this manuscript.
PR has been well described among otherwise healthy
patients treated for tuberculosis [12], although their risk
of PR is lower than that in tuberculosis patients with
HIV co-infection [13]. The mechanisms of PR in other-
wise healthy patients have been understood as recovery
from tuberculosis-induced immunosuppression leading
to a local hypersensitive response against massive myco-
bacterial antigens exposure following antituberculosis
treatment. Generally initial improvement on antituber-
culosis treatment is observed before PR in HIV− patients
[12], and the time from starting antituberculosis treat-
ment to PR is longer in HIV− patients as compared to
HIV-positive (HIV+) patients. Breen et al. reported that
the median time from starting antituberculosis treatment
to PR was 87 days in HIV− patients. However, in HIV+
tuberculosis patients the median time between starting
antiretroviral therapy and PR was only 11 days [13].
Since the times from starting tuberculosis treatment to
PR were relatively short in our cases (1 week and
3 weeks) compared to typical HIV− patients, PR in a
postpartum patient may be attributed to the continuation
of a preexisting hypersensitivity response to mycobacterial
antigens after initiation of tuberculosis treatment.
The onset of the first patient may be retrospectively
considered to be tuberclous pleurisy during the postpar-
tum period, although antibiotics therapy seemed to be
successful. The pathogenesis of tuberculous pleurisy is a
delayed-type hypersensitivity immunogenic reaction to a
few mycobacterial antigens entering the pleural space,
and resolution of the pleural effusion usually occurs
spontaneously without antituberculous chemotherapy.
However, about half of untreated cases of primary tuber-
culous pleurisy develop into more severe forms of active
pulmonary and/or extra-pulmonary tuberculosis [14].
Moreover, a previous report indicated that about 90 % of
the patients with postpartum tuberculosis had extra-
pulmonary tuberculosis, including pleuritis, peritonitis
and CNS infection [7]. Therefore, we speculate that the
entire course of the first patient is consistent with the
progression of postpartum tuberculosis.
Peritoneal tuberculosis is occasionally accompanied by
adnexal lesions, and elevated serum CA125 level may
also be found in cases of pelvic inflammation as shown
in our case [15]. Therefore the clinical features of peri-
toneal tuberculosis rather resemble ovarian carcinoma,
diagnosis of which usually leads to radical surgery. Actu-
ally, a number of patients, who were suspected pre-
operatively as having ovarian malignancy, proved to be
peritoneal tuberculosis by resected specimens [15]. In
addition, several cases of abdominal tuberculosis, which
deteriorated during antituberculosis treatment as PR,
have been reported [12, 16, 17]. For postpartum patients
with peritoneal tuberculosis mimicking ovarian cancer,
there is the additional consideration of PR during
chemotherapy to avoid erroneously judging that deteri-
oration during antituberculosis treatment is due to a
coexisting malignancy.
Historically the majority of psoas abscesses were caused
by tuberculosis of the vertebra, one of the typical manifes-
tations of extrapulmonary tuberculosis. More recently,
psoas abscesses are mainly caused by Staphylococcus aur-
eus as a primary abscess [18]. Although several bacterial
psoas abscesses have been reported during pregnancy and
subsequent to normal vaginal delivery, cesarean section
and abortion, tuberculous psoas abscess in obstetrics is
extremely rare and only two cases during pregnancy have
been reported [19]. Our second case is the first report of
postpartum tuberculous psoas abscess, which is secondary
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to spondylitis. Persistent lower back pain in postpartum
women should be investigated with clinical suspicion of a
psoas abscess and/or spondylitis. Interestingly, a case of a
young man with systemic lymph node tuberculosis which
progressed to psoas abscess caused by a PR has been re-
ported [20], suggesting that, as with lower back pain, we
need to consider the possibility of psoas abscess even after
the start of antituberculosis treatment.
The prognosis of postpartum tuberculosis is rela-
tively poor [1]. Therefore, more clinical and basic stud-
ies are needed in order to allow better management of
PR in postpartum tuberculosis. Especially, the use of
systemic steroids to suppress the hypersensitivity re-
sponse in postpartum patients should be evaluated,
since steroid treatment for PR in HIV− patients is con-
troversial over the owing to the absence of randomized
controlled studies.
Conclusion
In summary, careful observation with systemic examina-
tions on various extrapulmonary lesions is essential for
clinical practice in postpartum tuberculous, and recogni-
tion of the PR within a relatively short time after the initi-
ation of treatment is necessary to evaluate the effectiveness
of the treatment.
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